caa a22 4500 445312157 CHVBK 20180317142634.0 cr unu---uuuuu 170323e20110701xx s 000 0 eng 10.1007/s11095-011-0432-7 doi (NATIONALLICENCE)springer-10.1007/s11095-011-0432-7 The Alabama Drug Discovery Alliance: A Collaborative Partnership to Facilitate Academic Drug Discovery [Elektronische Daten] [Maaike Everts, W. Knight, David Harris, John Secrist III, Richard Whitley] ABSTRACT: The Alabama Drug Discovery Alliance is a collaboration between the University of Alabama at Birmingham and Southern Research Institute that aims to support the discovery and development of therapeutic molecules that address an unmet medical need. The alliance builds on the expertise present at both institutions and has the dedicated commitment of their respective technology transfer and intellectual property offices to guide any commercial opportunities that may arise from the supported efforts. Although most projects involve high throughput screening, projects at any stage in the drug discovery and development pathway are eligible for support. Irrespective of the target and stage of any project, well-functioning interdisciplinary teams are crucial to a project's progress. These teams consist of investigators with a wide variety of expertise from both institutions to contribute to the program's success. Springer Science+Business Media, LLC, 2011 academic drug discovery nationallicence Alabama nationallicence University of Alabama at Birmingham nationallicence high throughput screening nationallicence Southern Research Institute nationallicence ADDA : Alabama Drug Discovery Alliance nationallicence CCC : Comprehensive Cancer Center nationallicence CCTS : Center for Clinical and Translational Science nationallicence FDA : Food and Drug Administration nationallicence HTS : high throughput screening nationallicence IP : intellectual property nationallicence SR : Southern Research Institute nationallicence UAB : University of Alabama at Birmingham nationallicence Everts Maaike School of Medicine, University of Alabama at Birmingham, CHB 303; 1600 7th Ave S, 35233, Birmingham, Alabama, USA aut Knight W. Southern Research Institute, Birmingham, Alabama, USA aut Harris David Southern Research Institute, Birmingham, Alabama, USA aut Secrist III John Southern Research Institute, Birmingham, Alabama, USA aut Whitley Richard School of Medicine, University of Alabama at Birmingham, CHB 303; 1600 7th Ave S, 35233, Birmingham, Alabama, USA aut Pharmaceutical Research Springer US; http://www.springer-ny.com 28/7(2011-07-01), 1454-1459 0724-8741 28:7<1454 2011 28 11095 https://doi.org/10.1007/s11095-011-0432-7 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s11095-011-0432-7 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Everts Maaike School of Medicine, University of Alabama at Birmingham, CHB 303; 1600 7th Ave S, 35233, Birmingham, Alabama, USA aut NATIONALLICENCE 700 1- Knight W. Southern Research Institute, Birmingham, Alabama, USA aut NATIONALLICENCE 700 1- Harris David Southern Research Institute, Birmingham, Alabama, USA aut NATIONALLICENCE 700 1- Secrist III John Southern Research Institute, Birmingham, Alabama, USA aut NATIONALLICENCE 700 1- Whitley Richard School of Medicine, University of Alabama at Birmingham, CHB 303; 1600 7th Ave S, 35233, Birmingham, Alabama, USA aut NATIONALLICENCE 773 0- Pharmaceutical Research Springer US; http://www.springer-ny.com 28/7(2011-07-01), 1454-1459 0724-8741 28:7<1454 2011 28 11095 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer